Description
P3.07 Feasibility of analyzing BCR-ABL1 transcripts on bone marrow samples using the GeneXpert system
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: P3.07 Feasibility of analyzing BCR-ABL1 transcripts on bone marrow samples using the GeneXpert system
€2.42
